Stamford, CT -- (SBWIRE) -- 01/10/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Sangamo Biosciences, Inc. (NASDAQ:SGMO), GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), eHealth, Inc. (NASDAQ:EHTH), XOMA Corp (NASDAQ:XOMA)
Sangamo Biosciences, Inc. (NASDAQ:SGMO) opened the session at $15.70, trading in a range of $15.70 - $19.12. The stock showed a positive performance of 38.32% in the last trading session from its previous close of $13.65 and closed at $18.88. The stock traded on a volume of 10.38 million shares and the average volume of the stock remained 789,505 shares. Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of zinc finger deoxyribonucleic acid (DNA)-binding proteins (ZFPs), a naturally occurring class of proteins. ZFPs can be engineered to make ZFP nucleases (ZFNs), proteins that can be used to modify DNA sequences in a variety of ways and ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off.
For How Long SGMO will Fight for Profitability? Read This Trend Analysis report
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) traded 2.15 million shares in the last business day while the average volume of the stock remained 86,070 shares. The stock showed a positive movement of +23.49% to end at $47.00. The 52 week range of the stock remained $8.46 - $48.95. GW Pharmaceuticals plc is a United Kingdom-based company. The Company is engaged in the research, development and commercialization of a range of cannabinoid prescription medicines to meet patient needs in a range of medical conditions. The Company is developing a portfolio of cannabinoid medicines, of which the main product is Sativex, an oromucosal spray for the treatment of Multiple Sclerosis (MS) symptoms, cancer pain and neuropathic pain.
For How Long GWPH’s Gloss will Attract Investors? Find out via this report
eHealth, Inc. (NASDAQ:EHTH) reported 1.27 million shares were exchanged during the last trade, while the average volume is about 290,022 shares. The stock escalated +20.68% and finished the day at $57.47 The beta of the stock is recorded at 0.73. eHealth, Inc. (eHealth) offers Internet-based health insurance agency services for individuals, families and small businesses in the United States, as well as technology licensing and Internet advertising services. The Company offers Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.
For How Long EHTH’s Gloss will Attract Investors? Find out via this report
XOMA Corp (NASDAQ:XOMA) shares rose, +14.11 percent from its previous close of $7.16 to close at $8.17. Traded with volume of 4.39 million shares in the prior session and the average volume of the stock remained 2.58 million shares. XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta). The Company’s preclinical pipeline includes classes of antibodies that activate or sensitize the insulin receptor in vivo, named XMet, and represent potential new therapeutic approaches to the treatment of diabetes and several diseases that have insulin involvement. On January 17, 2012, it announced that it had acquired certain the United States rights to a portfolio of antihypertensive products from Servier.
Why Should Investors Buy XOMA After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)